Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation - Scorecard - MDSpire
Advertisement
Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation
Clinical Scorecard: Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation
At a Glance
Category
Detail
Condition
Retinal degenerative diseases
Key Mechanisms
Inhibition of valosin-containing protein (VCP) to preserve photoreceptor structure and function
Target Population
Patients with inherited retinal diseases (IRDs)
Care Setting
Preclinical research using organotypic retinal explants
Key Highlights
ML240 shows a comprehensive preclinical safety profile across species.
Retinal explants from pigs, macaques, and humans were used for evaluation.
ML240 was tested both as a free compound and in nanoparticle form.
The study supports ML240 as a mutation-independent therapeutic candidate.
Guideline-Based Recommendations
Diagnosis
Utilize organotypic retinal explants for safety and efficacy assessments.
Management
Consider ML240 for therapeutic development in retinal degenerative diseases.
Monitoring & Follow-up
Assess photoreceptor viability and microglial reactivity in explants.
Risks
Monitor for potential toxicity associated with VCP inhibition.
Patient & Prescribing Data
Individuals diagnosed with inherited retinal diseases (IRDs)
ML240 may provide neuroprotective effects without the toxicity seen in traditional models.
Clinical Best Practices
Incorporate large-animal and human-derived models in preclinical studies.
Evaluate drug delivery strategies to enhance efficacy and reduce toxicity.
Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia
